-
Company Profile
Tetraphase Pharmaceuticals Inc – Company Profile
Tetraphase Pharmaceuticals Inc (Tetraphase), a subsidiary of La Jolla Pharmaceutical Company, is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include Xerava (eravacycline), TP-271, TP-2846 and TP-6076. It develops products for the treatment of respiratory diseases caused by bacterial biothreat and antibiotic-resistant public health pathogens. Tetraphase’s eravacycline is used for the treatment of multi-drug resistant (MDR) infections which include MDR gram-negative bacteria. The company offers drugs in therapeutic areas of antibiotics, oncology...
Add to Basket -
Product Insights
Appendicitis Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, H1, 2020" provides an overview of Appendicitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Appendicitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Escherichia Coli Infections Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Escherichia coli Infections Global Clinical Trials Review, H1, 2020" provides an overview of Escherichia coli Infections scenario. This report provides top line data relating to the clinical trials on Escherichia coli Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Community-Acquired Infections Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Community-Acquired Infections Global Clinical Trials Review, H1, 2019" provides an overview of Community-Acquired Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Community-Acquired Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Complicated Intra-Abdominal Infections Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Complicated Intra-Abdominal Infections Global Clinical Trials Review, H1, 2019" provides an overview of Complicated Intra-Abdominal Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Complicated Intra-Abdominal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Appendicitis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Appendicitis Global Clinical Trials Review, H2, 2018" provides an overview of Appendicitis clinical trials scenario. This report provides top line data relating to the clinical trials on Appendicitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
PharmaPoint: Healthcare-Associated Gram-Negative Infections – Global Drug Forecast and Market Analysis to 2026
Healthcare-associated infections (HAIs) are a major threat to patient safety, and place a substantial economic burden on healthcare systems. HAIs occur in hospitalized patients, and are not present at the time of admission. Acute care hospitals are the primary settings for contracting HAIs, with a high concentration occurring within non-nursery wards and intensive care units (ICUs).The most common types of HAIs are related to the use of invasive devices or surgical procedures, and fall into the following infection site categories:...
-
Product Insights
Escherichia coli Infections Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Escherichia coli Infections Global Clinical Trials Review, H2, 2017" provides an overview of Escherichia coli Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Escherichia coli Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Community-Acquired Infections Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Community-Acquired Infections Global Clinical Trials Review, H1, 2017" provides an overview of Community-Acquired Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Community-Acquired Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Complicated Intra-Abdominal Infections Global Clinical Trials Review, H1, 2017" provides an overview of Complicated Intra-Abdominal Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Complicated Intra-Abdominal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...